scispace - formally typeset
R

Rebecca E. Koscik

Researcher at University of Wisconsin-Madison

Publications -  6
Citations -  698

Rebecca E. Koscik is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Cystic fibrosis & Newborn screening. The author has an hindex of 6, co-authored 6 publications receiving 675 citations. Previous affiliations of Rebecca E. Koscik include University of Wisconsin Hospital and Clinics.

Papers
More filters
Journal ArticleDOI

Nutritional Benefits of Neonatal Screening for Cystic Fibrosis

TL;DR: In this article, the nutritional status of patients with cystic fibrosis identified by neonatal screening or by standard diagnostic methods was compared for up to 10 years by anthropometric and biochemical methods in 56 infants who received an early diagnosis and in 40 infants in which the diagnosis was made by standard methods.
Journal ArticleDOI

Sweat Chloride Concentrations in Infants Homozygous or Heterozygous for F508 Cystic Fibrosis

TL;DR: Quantitative pilocarpine iontophoresis can be used successfully in infants younger than 6 weeks of age who are undergoing routine diagnostic evaluations to follow up newborn screening test results that are positive for CF.
Journal ArticleDOI

Effect of linoleic acid intake on growth of infants with cystic fibrosis

TL;DR: The results suggest that a high linoleic acid content in formula benefits infants with CF because it optimizes nutrition, growth, and feeding efficiency.
Journal ArticleDOI

Wisconsin cystic fibrosis chest radiograph scoring system: validation and standardization for application to longitudinal studies.

TL;DR: A final modeling, validation, and standardization plan for the Wisconsin cystic fibrosis chest radiographic scoring system was designed and it was found that an additive method of total score computation is significantly more reliable than either the original multiplicative model or the traditional Brasfield scoring system.
Journal ArticleDOI

Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults

TL;DR: Over a 4-year interval, asymptomatic middle-aged adults with FH of AD exhibit significant atrophy in the posterior hippocampi in the absence of measurable cognitive changes, providing further evidence that detectable disease-related neuroanatomic changes do occur early in the AD pathologic cascade.